Tom Martin
About Tom Martin
Tom Martin is the Submission Manager for Global Dossier Management at Bristol Myers Squibb and President of TGM Pharmaceutical Consulting, with over twenty years of experience in the pharmaceutical industry.
Current Position at Bristol Myers Squibb
Tom Martin currently works as a Submission Manager in the Global Dossier Management department at Bristol Myers Squibb, based in Lawrenceville, NJ. His role involves coordinating and managing the submission processes for regulatory dossiers on a global scale. This position leverages his extensive background in regulatory affairs and quality compliance.
Previous Experience at Teva Pharmaceuticals
Tom Martin has held several roles at Teva Pharmaceuticals. From 2017 to 2018, he served as a Regulatory Affairs Associate III in Horsham, PA. Prior to that, he was a Regulatory Affairs Associate from 2015 to 2017 in the same location. During his time at Teva, he contributed to regulatory submissions and compliance activities.
Roles at McNeil Consumer Healthcare
From 2004 to 2015, Tom Martin worked at McNeil Consumer Healthcare in R&D for Marketed Products under the Pharmaceutical Technology and Technical Operations Support department. His long tenure at McNeil equipped him with significant experience in research and development as well as operational support for marketed pharmaceutical products.
Education Background
Tom Martin studied Natural Sciences and Mathematics at Thomas Edison State College, where he earned a Bachelor of Arts degree. He also pursued a Bachelor of Science in Chemistry at Drexel University. Furthermore, he obtained an Associate of Arts in Chemistry from Bucks County Community College. His educational background provides a strong foundation for his expertise in the pharmaceutical industry.
Leadership at TGM Pharmaceutical Consulting
Tom Martin holds the position of President at TGM Pharmaceutical Consulting. In this role, he oversees consulting operations focused on pharmaceutical compliance, regulatory affairs, and quality management. His leadership and strategic direction contribute to the company's success in the pharmaceutical consulting domain.